{"transactions":[{"id":712537,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock option (right to buy)","published_at":"2026-07-09T01:13:50.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on May 28, 2026, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2026 Annual Meeting of Stockholders. Such stockholder approval was obtained on July 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from May 28, 2026, with 1/3 vesting on the first anniversary of May 28, 2026, and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of May 28, 2026."}],"balance_after":92000,"derivative":{"exercise_price":3.14,"expiration_date":"2036-05-28","underlying":"Common stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001104659-26-082018","document":"tm2620095-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465926082018/tm2620095-9_4seq1.xml","form_type":"4"}},{"id":1092107,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants","published_at":"2025-07-03T12:00:13.000Z","date":"2025-07-02","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.01,"value":50.0,"ownership":{"direct":true},"balance_after":5000,"derivative":{"exercise_price":5.25,"exercise_date":"2025-07-02","expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-25-065570","document":"tm2519819-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925065570/tm2519819-1_4seq1.xml","form_type":"4"}},{"id":1092106,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-03T12:00:13.000Z","date":"2025-07-02","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.99,"value":24950.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This number has been adjusted for the one-for-thirty (1:30) reverse stock split effected by the Issuer on June 24, 2025."}],"balance_after":6418,"source":{"system":"sec-edgar","filing":"0001104659-25-065570","document":"tm2519819-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925065570/tm2519819-1_4seq1.xml","form_type":"4"}},{"id":1263512,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-02-18T21:04:18.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest over a period of three years from February 14, 2025, with 1/3 vesting on the first anniversary of February 14, 2026 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of February 14, 2026."}],"balance_after":290000,"derivative":{"exercise_price":0.29,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001104659-25-014742","document":"tm256830-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925014742/tm256830-4_4seq1.xml","form_type":"4"}},{"id":1475022,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-06-18T21:04:06.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on December 15, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from December 15, 2023, with 1/3 vesting on the first anniversary of Decembner 15, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of Decembner 15, 2023."}],"balance_after":290000,"derivative":{"exercise_price":2.65,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001104659-24-072887","document":"tm2417520-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465924072887/tm2417520-8_4seq1.xml","form_type":"4"}},{"id":1713990,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-12-13T01:07:49.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":104000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on January 16, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2023 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 23, 2023. Because January 16, 2023 was a federal holiday, the option was priced on the following trading day."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from January 17, 2023, with 1/3 vesting on the first anniversary of January 17, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of January 17, 2023."}],"balance_after":104000,"derivative":{"exercise_price":1.68,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":104000},"source":{"system":"sec-edgar","filing":"0001104659-23-125486","document":"tm2332764-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923125486/tm2332764-2_4seq1.xml","form_type":"4"}},{"id":1713989,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-13T01:07:49.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":42554,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":42578,"source":{"system":"sec-edgar","filing":"0001104659-23-125486","document":"tm2332764-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923125486/tm2332764-2_4seq1.xml","form_type":"4"}},{"id":2052234,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-01-18T23:33:02.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":104000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":104000,"derivative":{"exercise_price":1.68,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":104000},"source":{"system":"sec-edgar","filing":"0001104659-23-004699","document":"tm233841-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923004699/tm233841-1_4seq1.xml","form_type":"4"}},{"id":2374410,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-02-24T22:00:59.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in three equal annual installments beginning on the first anniversary of the date of grant."}],"balance_after":150000,"derivative":{"exercise_price":0.49,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-22-006594","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114036122006594/form4.xml","form_type":"4"}},{"id":4348560,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common stock","published_at":"2017-04-20T22:02:00.000Z","date":"2017-04-18","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common stock grant that vests in equal annual increments on March 2, 2018, March 2, 2019, and March 2, 2020."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001144204-17-021331","document":"v464726_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114420417021331/v464726_form4.xml","form_type":"4"}}]}